|
Online Database of Chemicals from Around the World | 产品搜索 | 产品提交 | 产品推广 | |
网站主页 >> 化工产品目录 >> 头孢地洛尔>> 市场分析报告 |
头孢地洛尔市场分析报告 |
|
Global Cefiderocol Sulfate Tosylate Industry Research Report, Competitive Landscape, Market Size, Regional Status and Prospect ... as well as a deep insight into the Cefiderocol Sulfate Tosylate market covering all ... and Chapter 7.3, based on types, the Cefiderocol Sulfate Tosylate market from 2017 ... and Chapter 7.4, based on applications, the Cefiderocol Sulfate Tosylate market from 2017 ... Global Klebsiella Pneumoniae Infection Drug Market Report 2020 ... Segmentation ATI-1503 CA-824 CC-1807 Cefiderocol Debio-1454 Industry Segmentation Hospital ... Global Infectious Disease Treatment Market - 2025 -2033 ... . Similarly, Shionogi’s Fetroja (cefiderocol), approved for carbapenem-resistant ... bacteria. Additionally, Shionogi’s Fetroja (cefiderocol), a siderophore cephalosporin, addresses ... such as Shionogi’s Fetroja (cefiderocol) and hospital-targeted therapies ... Global Klebsiella Pneumoniae Infection Drug Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028 ... , covers ATI-1503 CA-824 CC-1807 Cefiderocol Debio-1454 EBX-004 Others ... Klebsiella Pneumoniae Infection Drug Market - Global Outlook and Forecast 2022-2028 ... , 2021 (%) ATI-1503 CA-824 CC-1807 Cefiderocol Debio-1454 EBX-004 Others ... Anti-Infective Agents Market Size, Share & Trends Analysis Report By Type (Antibacterial, Antiviral, Antifungal & Antiparasitic), By Route Of Administration (Oral, Parenteral), By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2030 ... New Drug Application (NDA) for cefiderocol, a novel siderophore cephalosporin antibiotic, has ... by the Center for Drug Evaluation. Cefiderocol targets gram-negative bacteria, including ... Hospital Acquired Pneumonia (HAP) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Hospital Acquired Pneumonia (HAP) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Hospital Acquired Pneumonia (HAP) - ... Ventilator Associated Pneumonia (VAP) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Ventilator Associated Pneumonia (VAP) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Ventilator Associated Pneumonia ( ... Resistant Pseudomonas aeruginosa Infections - Pipeline Review, H2 2020 Resistant Pseudomonas aeruginosa Infections - Pipeline Review, H2 2020 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Resistant Pseudomonas aeruginosa Infections - Pipeline Review, H2 2020, provides an overview ... Resistant Pseudomonas aeruginosa Infections - Pipeline Review, H1 2020 Resistant Pseudomonas aeruginosa Infections - Pipeline Review, H1 2020 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Resistant Pseudomonas aeruginosa Infections - Pipeline Review, H1 2020, provides an overview ... Klebsiella pneumoniae Drug Development Pipeline Study, H2 2018 Klebsiella pneumoniae Drug Development Pipeline Study, H2 2018 is the latest infectious disease publication with comprehensive information of Klebsiella pneumoniae pipeline products. DISEASE OVERVIEW Klebsiella pneumoniae belongs to the class of Gram- ... Sepsis - Pipeline Insight, 2021 ... alkaline phosphatase ART-123 Alirocumab Cefiderocol Remimazolam Nangibotide CaCP29 Allocetra-OTS ... Resistant Pseudomonas aeruginosa Infections (Infectious Disease) - Drugs In Development, 2021 Resistant Pseudomonas aeruginosa Infections (Infectious Disease) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Resistant Pseudomonas aeruginosa Infections - Drugs In Development, ... 2023-2028 Global and Regional Klebsiella Pneumoniae Infection Drug Industry Status and Prospects Professional Market Research Report Standard Version ... By Types: ATI-1503 CA-824 CC-1807 Cefiderocol Debio-1454 EBX-004 Others ... Global Cephalosporin Drugs Market Size Study & Forecast, by Generation (First-generation, Second-generation, Third-generation, Fourth-generation, Fifth-generation), by Prescription (Prescription Drugs, OTC Drugs), and Regional Analysis, 2023-2030 ... ) signed a collaborative agreement to increase access to cefiderocol in over 70% of nations globally. This deal ... Bacterial Pneumonia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034 The 7 major bacterial pneumonia markets reached a value of US$ 2.0 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 3.6 Billion by 2034, exhibiting a growth rate (CAGR) of 5.44% during 2024-2034. The bacterial pneumonia market has ... Complicated Urinary Tract Infections (cUTIs) Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034 The 7 major complicated urinary tract infections (cUTIs) markets are expected to exhibit a CAGR of 5.6% during 2024-2034. The complicated urinary tract infections (cUTIs) market has been comprehensively analyzed in IMARC's new report titled "Complicated ... Pneumonia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034 The 7 major pneumonia markets are expected to exhibit a CAGR of 5.32% during 2024-2034. The pneumonia market has been comprehensively analyzed in IMARC's new report titled "Pneumonia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, ... Sepsis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034 The 7 major sepsis markets reached a value of US$ 438.4 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 907.3 Million by 2034, exhibiting a growth rate (CAGR) of 6.84% during 2024-2034. The sepsis market has been comprehensively ... Global Klebsiella Pneumoniae Infection Drug Market Research Report 2024(Status and Outlook) ... (by Type) ATI-1503 CA-824 CC-1807 Cefiderocol Debio-1454 EBX-004 Others ... |